What is the recommended amoxicillin‑clavulanate dosing for a pediatric patient, including dose augmentation for severe infections and adjustments for renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin-Clavulanate Dosing for Pediatric Patients

For pediatric patients ≥3 months old with severe infections requiring augmented dosing, use 90 mg/kg/day of the amoxicillin component divided every 12 hours (45 mg/kg/dose), or 40 mg/kg/day divided every 8 hours for the standard formulation. 1, 2

Standard Dosing by Age and Severity

Neonates and Infants <3 months

  • 30 mg/kg/day divided every 12 hours (based on amoxicillin component)
  • Use the 125 mg/5 mL oral suspension formulation 3

Patients ≥3 months old

For severe infections (otitis media, sinusitis, lower respiratory tract infections):

  • 45 mg/kg/day every 12 hours using 200 mg/5 mL or 400 mg/5 mL suspension
  • Alternative: 40 mg/kg/day every 8 hours using 125 mg/5 mL or 250 mg/5 mL suspension 3

For less severe infections:

  • 25 mg/kg/day every 12 hours, or
  • 20 mg/kg/day every 8 hours 3

Patients ≥40 kg

Dose according to adult recommendations:

  • Standard: 500 mg/125 mg every 12 hours or 250 mg/125 mg every 8 hours
  • Severe infections/respiratory tract: 875 mg/125 mg every 12 hours or 500 mg/125 mg every 8 hours 3

Critical Considerations for Augmented Dosing

Critically Ill Children

In critically ill pediatric patients, particularly those post-cardiac surgery or in ICU settings, standard dosing is frequently inadequate due to augmented renal clearance. Recent pharmacokinetic studies demonstrate that:

  • Four-hourly dosing (every 4 hours instead of every 6 hours) is required to achieve therapeutic targets in patients with augmented clearance 4, 5
  • Standard 6-hourly dosing results in subtherapeutic concentrations in 32% of critically ill children, leading to clinical failure 5
  • Only patients receiving vasopressors maintain adequate drug exposure with standard 6-hourly dosing, as vasopressors decrease clearance by approximately one-third 4

Practical algorithm for critically ill children:

  1. If on vasopressors: Use standard 6-hourly dosing (25-35 mg/kg every 6 hours)
  2. If NOT on vasopressors: Increase to 4-hourly dosing (25 mg/kg every 4 hours) 4, 5
  3. Consider 1-hour infusion rather than bolus dosing in patients with augmented renal function 5

Renal Impairment Adjustments

GFR 10-30 mL/min:

  • 500 mg/125 mg or 250 mg/125 mg every 12 hours (severity-dependent) 3

GFR <10 mL/min:

  • 500 mg/125 mg or 250 mg/125 mg every 24 hours (severity-dependent) 3

Hemodialysis patients:

  • 500 mg/125 mg or 250 mg/125 mg every 24 hours
  • Additional dose during and at end of dialysis 3
  • Fractional drug removal during hemodialysis is approximately 64% for amoxicillin and 65% for clavulanate 6

Important Formulation Warnings

Do NOT substitute formulations interchangeably:

  • Two 250 mg/125 mg tablets ≠ one 500 mg/125 mg tablet (same clavulanate content)
  • 250 mg/125 mg tablet ≠ 250 mg/62.5 mg chewable tablet (different clavulanate ratios)
  • The 250 mg/125 mg tablet should not be used until child weighs ≥40 kg 3

Administration Recommendations

  • Administer at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 3
  • The every 12-hour regimen is preferred over every 8-hour dosing as it significantly reduces diarrhea incidence 3

Common Pitfalls

  1. Underdosing in critically ill children: Standard dosing fails in 32% of ICU patients due to augmented clearance—consider 4-hourly dosing 5
  2. Forgetting dialysis supplementation: Always give additional doses during and after hemodialysis 3
  3. Using adult formulations in small children: The 875 mg/125 mg dose should not be used in patients with GFR <30 mL/min 3
  4. Incorrect formulation substitution: Different formulations contain different clavulanate ratios and are not interchangeable 3

Related Questions

What is the appropriate dosing regimen of Augmentin (amoxicillin/clavulanate) for a patient receiving dialysis?
What is the recommended intravenous administration regimen for co-amoxiclav, including dosing, infusion duration, and adjustments for renal impairment and pediatric patients?
What is the appropriate Augmentin (amoxicillin + clavulanate) dosage for a 12-year-old child weighing approximately 40–45 kg with normal kidney and liver function?
What are the recommended amoxicillin dosing regimens for adults and children, and how should the dose be adjusted in renal impairment?
What is the recommended dosing, administration, and contraindications for amoxicillin/clavulanate (co‑amoxiclav) in adults?
What are the differences between Focalin XR (dexmethylphenidate extended‑release) and Focalin IR (dexmethylphenidate immediate‑release) for treating attention‑deficit/hyperactivity disorder?
Do the provided complete blood count and testosterone laboratory results indicate any abnormality or require further evaluation?
What are the recommended types, dosing, and monitoring guidelines for intravenous fluid therapy in pediatric patients, including resuscitation bolus and maintenance calculations?
What are the guidelines for using isotonic crystalloids for resuscitation and maintenance in pediatric patients?
What are the possible signs of increased serum duloxetine effects when duloxetine is combined with ciprofloxacin?
Can duloxetine be used to treat an adult with post‑traumatic stress disorder and comorbid panic disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.